Thalidomide Articles
Celgene Designs New Series Of Anti-Inflammatories
4 September 1995
Adrulis' Thalidomide In Cytokine Test
14 August 1995
EMEA Fee Decision Expected This Week
23 January 1995
Celgene Starts Studies
2 January 1995
THALIDOMIDE TRIALS IN HIV
2 May 1994
REVIEW OF THALIDOMIDE AGREEMENT
28 March 1994
CELGENE TO FILE FOR THALIDOMIDE IN AIDS
10 January 1994
THALIDOMIDE PROMISEIN HIV TREATMENT
19 July 1993
PHARMA DIRECTION FOR BRITISH BIO-TECHNOLOGY
19 July 1993
SHAPING THE IMAGE OF THE PHARMA INDUSTRY
22 March 1993
THE UK DRUG INDUSTRYIN REVIEW: 1961-1991
4 May 1992
THAMIDOMIDE AS AN IMMUNOSUPPRESSANT
27 April 1992
CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV
6 April 1992
CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV
6 April 1992
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
